Regenerative therapies for male sexual dysfunction - a review article

Area of Science:

• Regenerative Medicine and Urology
• Investigating novel therapeutic modalities for sexual health conditions.

Background:

• Erectile dysfunction (ED) and Peyronie's disease (PD) are prevalent conditions impacting male sexual health.
• Emerging treatments include low-intensity extracorporeal shock wave therapy (Li-ESWT), stem cell therapy, and platelet-rich plasma (PRP) injections.
• Current evidence for these novel therapies is limited by inconsistent findings and methodological weaknesses.

Purpose of the Study:

• To review the current evidence for Li-ESWT, stem cell therapy, and PRP in treating ED and PD.
• To highlight the potential mechanisms of action, such as angiogenesis for Li-ESWT.
• To identify the need for standardized research to clarify clinical efficacy.

Main Methods:

• Review of existing clinical trials and preliminary studies on Li-ESWT, stem cell therapy, and PRP for ED and PD.
• Analysis of reported outcomes and methodological quality of the included studies.
• Identification of common limitations in current research protocols.

Main Results:

• Li-ESWT shows potential for promoting angiogenesis but clinical trial results for ED and PD are contradictory and often compromised.
• Preliminary studies suggest potential benefits for stem cell therapy and PRP, but their clinical efficacy is uncertain.
• Significant heterogeneity and methodological limitations were observed across studies.

Conclusions:

• Novel therapies like Li-ESWT, stem cell therapy, and PRP require further investigation for ED and PD.
• Standardized research protocols are essential to establish the true efficacy and safety of these treatments.
• More high-quality clinical trials are needed to guide therapeutic decisions in urology and sexual medicine.